Bay Area/ San Jose

Milpitas Medtech Shakeup As Endologix Shutters Plant And Cuts 31 Jobs

AI Assisted Icon
Published on March 11, 2026
Milpitas Medtech Shakeup As Endologix Shutters Plant And Cuts 31 JobsSource: Google Street View

Endologix LLC is pulling the plug on its Milpitas manufacturing site, filing a WARN notice to permanently close the facility and lay off 31 employees this spring. The company plans to phase in reductions starting May 6 and expects all separations to be wrapped up by the end of May 2026. The Milpitas operation has handled manufacturing and support work for the firm's vascular devices, leaving affected workers to look to local unemployment and retraining resources as the shutdown unfolds.

What the WARN filing says

According to WhatNow, Endologix filed its WARN notice with California officials on March 5, 2026, identifying its Milpitas site at 1971 Milmont Drive for permanent closure. The filing breaks the 31 affected positions into three rounds of layoffs: 23 jobs are slated to end on May 6, six more on May 15, and the final two on May 29. All of the separations are listed as permanent in the state paperwork.

Endologix's operations in California

Endologix, headquartered in Irvine and founded in 1992, develops minimally invasive devices to treat aortic and other major blood-vessel conditions, according to Endologix and business profiles. The company’s regulatory instructions for use list 1971 Milmont Drive, Milpitas, CA, as a manufacturer address, corroborating the site named in the WARN filing, per FDA documents.

What WARN means for workers

Under California law, covered employers are generally required to give at least 60 days of notice before plant closings or mass layoffs, according to the California Employment Development Department. The agency also outlines rapid-response and retraining services that local workforce boards can offer to affected employees once a notice is filed, including help connecting workers with new opportunities.

Local context

The Milpitas cuts land amid a broader wave of life-science and medtech consolidation in the Bay Area, where other firms have recently announced facility closures and staff reductions. For example, a December 2025 state filing showed a San Jose site closure that eliminated 121 jobs in the region, per Hoodline.

The WARN notice for Milpitas did not include a reason for the shutdown, according to WhatNow, and company officials have not provided additional details in the filing. Affected employees can look for benefit information and retraining resources through local American Job Centers and the California Employment Development Department layoff services page.